V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20133308 | 20087622 | null | null | Adjuvant (A) | null | 2019-06-16 | FOXTROT TRIAL | 01 | N | EVEROLIMUS | 101211816 |
| 20133496 | 20087623 | 1.75 | null | null | 2019-06-22 | 2019-07-07 | Bendamustine+Rituximab (1st Course) | 02 | N | BORTEZOMIB + MELPHALAN | 100415174 |
| 20133526 | 20087624 | 1.73 | 53.8 | Palliative (P) | 2019-07-06 | 2019-07-13 | Abiraterone | 02 | Y | BALLAD TRIAL | 101369305 |
| 20133659 | 20087625 | 1.57 | null | Palliative (P) | 2020-11-10 | 2020-11-11 | CEMIPLIMAB | N | N | EOF | 100701583 |
| 20133841 | 20087626 | null | null | Palliative (P) | 2017-12-01 | 2017-12-01 | R Chlorambucil | 02 | N | ESPAC TRIAL | 100088563 |
| 20133853 | 20087627 | 1.49 | 112 | Adjuvant (A) | 2018-03-24 | 2018-04-02 | CHOP R - 21 days | 02 | N | RITUXIMAB | 100014493 |
| 20134283 | 20087629 | 1.66 | 76 | null | 2010-12-08 | 2017-04-03 | IPILIMUMAB + NIVOLUMAB | 01 | N | CYCLOPHOSPHAMIDE | 101408901 |
| 20134708 | 20087632 | 1.69 | 105 | Palliative (P) | 2017-08-14 | 2017-08-14 | PHITT C CDDP-M | N | N | CAPECITABINE + OXALIPLATIN + RT | 100003185 |
| 20134715 | 20087633 | 1.8 | 97 | 03 | 2016-06-05 | 2016-06-13 | CARBOPLATIN + FLUOROURACIL | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 100907912 |
| 20134721 | 20087634 | 1.81 | 108.6 | 03 | null | 2018-12-28 | Cisplatin + Fluorouracil + RT 5day | null | N | CISPLATIN + FLUOROURACIL + MITOMYCIN | 100284389 |
| 20134734 | 20087635 | 0 | 45.3 | Palliative (P) | 2017-06-20 | 2017-06-20 | EEF or EOF | N | N | SCOPE2 TRIAL | 101159006 |
| 20134770 | 20087636 | 1.85 | 57 | Palliative (P) | null | 2018-07-07 | Rituximab | N | N | DOXORUBICIN | 101506005 |
| 20134794 | 20087637 | 1.6 | 60 | null | 2021-02-09 | 2021-02-09 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | CYCLOPHOSPHAMIDE | 101285528 |
| 20134840 | 20087638 | 1.57 | 82.2 | Palliative (P) | 2018-05-11 | 2018-05-17 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100714938 |
| 20134851 | 20087639 | 1.67 | 63 | 03 | 2017-08-12 | 2017-08-14 | Rituximab | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100165138 |
| 20134868 | 20087640 | 1.82 | 87.65 | Adjuvant (A) | 2018-03-13 | 2018-03-13 | HEP SIOPEL 3, PLADO | N | N | GEMCITABINE + PACLITAXEL | 101543241 |
| 20134872 | 20087641 | 1.81 | 92.4 | 03 | 2016-04-24 | 2016-05-04 | ACTICCA-1 Trial | 02 | null | CISPLATIN + FLUOROURACIL + RT | 101696186 |
| 20134887 | 20087642 | 1.65 | 73.4 | null | 2019-06-26 | 2019-07-06 | ECarboX | 02 | null | DOCETAXEL | 101714793 |
| 20135005 | 20087643 | 1.77 | 74 | null | 2019-08-13 | 2019-09-03 | null | 02 | N | CAP + RT | 101151596 |
| 20135010 | 20087644 | 1.78 | 14.8 | Palliative (P) | 2017-02-02 | 2017-02-26 | EOF | 02 | N | IPILIMUMAB + NIVOLUMAB | 101103854 |
| 20135121 | 20087645 | 1.64 | 66 | 03 | 2018-02-17 | 2018-03-10 | CAP + RT | N | N | ESPAC TRIAL | 101133199 |
| 20135123 | 20087646 | null | 73.4 | null | null | 2017-09-28 | ECarboF | null | N | PACLITAXEL + TRASTUZUMAB | 101225962 |
| 20135185 | 20087647 | 1.68 | 61.8 | Palliative (P) | 2019-12-13 | 2020-01-08 | ARISTOTLE TRIAL | 02 | N | MCX | 101110654 |
| 20135356 | 20087648 | 1.82 | null | 03 | 2019-03-17 | 2019-03-17 | CARBOPLATIN + FLUOROURACIL | 02 | N | MCX | 101403654 |
| 20135389 | 20087649 | 1.73 | 49.3 | 03 | 2021-05-03 | 2021-05-04 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CARBOPLATIN + FLUOROURACIL | 101563665 |
| 20135442 | 20087650 | 1.54 | 78 | 03 | 2016-02-11 | 2016-02-25 | Cisplatin + Fluorouracil + Streptozocin | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101724864 |
| 20135459 | 20087651 | 0 | 0 | Adjuvant (A) | 2017-07-20 | 2017-08-16 | GO2 TRIAL | N | N | GEMCITABINE + PACLITAXEL | 101253577 |
| 20135959 | 20087652 | 1.7 | 73.9 | 03 | 2021-10-07 | 2021-10-12 | R Chlorambucil | 02 | N | CARBOPLATIN + FLUOROURACIL | 100290402 |
| 20136217 | 20087653 | 1.87 | 73.3 | null | 2019-07-28 | 2019-08-01 | ESPAC-4 TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL | 100015026 |
| 20136351 | 20087654 | 1.67 | null | Palliative (P) | 2019-10-01 | 2019-10-02 | CISPLATIN + FLUOROURACIL + Trastuzumab | 01 | N | RALTITREXED | 100060612 |
| 20136372 | 20087655 | 0 | 0 | 03 | 2020-01-02 | 2020-01-16 | DABRAFENIB + TRAMETINIB | 02 | N | AFATINIB | 100360565 |
| 20136470 | 20087656 | 1.76 | 58.65 | Palliative (P) | 2017-06-15 | 2017-06-15 | IBRUTINIB | 02 | N | HYDROXYCARBAMIDE | 101538515 |
| 20136480 | 20087657 | 1.75 | 73 | Palliative (P) | 2018-07-06 | 2018-07-27 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CARBOPLATIN + VINORELBINE | 100018406 |
| 20136481 | 20087658 | 1.74 | 82.8 | 03 | 2016-11-24 | 2016-11-25 | Bortezomib +/- Dexamethasone | N | N | CARBOPLATIN + TEYSUNO | 100512315 |
| 20136732 | 20087659 | 1.85 | 78 | 03 | 2017-09-12 | 2017-09-18 | LENALIDOMIDE | 02 | N | CETUXIMAB + RT | 100441243 |
| 20136771 | 20087660 | 0 | 0 | Palliative (P) | 2019-08-25 | 2019-08-25 | CAPECITABINE + CETUXIMAB + IRINOTECAN | null | null | RITUXIMAB | 100470005 |
| 20136825 | 20087661 | 1.58 | 59.85 | Palliative (P) | 2019-03-05 | 2019-03-06 | EEF or EOF | 02 | N | DOXORUBICIN | 101841122 |
| 20137000 | 20087662 | 1.6 | 67.7 | Neo-adjuvant (N) | 2018-10-02 | 2018-10-24 | EEF or EOF | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100736000 |
| 20137001 | 20087663 | 1.6 | 58.6 | null | 2017-12-04 | 2017-12-21 | LENALIDOMIDE | 02 | Y | BCG | 101120480 |
| 20137439 | 20087666 | 1.74 | 142 | null | 2016-05-28 | 2016-05-30 | CTD | 02 | N | EVEROLIMUS | 101455618 |
| 20137502 | 20087667 | 1.78 | 91.2 | Palliative (P) | null | 2020-09-09 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | GO2 TRIAL | 101078161 |
| 20137533 | 20087668 | 1.79 | 85 | 03 | 2019-03-07 | 2019-03-19 | Cisplatin + Fluorouracil + Streptozocin | 01 | N | REGORAFENIB | 101488838 |
| 20137633 | 20087669 | 1.77 | 76.8 | Palliative (P) | 2017-05-12 | 2019-11-30 | FCarboSt | 02 | N | PACLITAXEL | 101081602 |
| 20137750 | 20087670 | 1.69 | 65 | Adjuvant (A) | 2020-03-06 | 2020-03-13 | CHOP R - 21 days | 02 | N | RALTITREXED | 100617711 |
| 20137799 | 20087672 | 0 | 0 | Palliative (P) | 2019-11-10 | 2019-11-17 | PLATFORM Trial | 02 | N | ATEZOLIZUMAB | 101459893 |
| 20138126 | 20087674 | 1.54 | 44 | Palliative (P) | 2018-01-10 | 2018-01-18 | ANAGRELIDE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101600837 |
| 20138148 | 20087675 | 1.76 | 58.3 | 03 | 2017-05-05 | 2017-05-19 | ABVD | N | N | ACELARATE TRIAL | 100607115 |
| 20138247 | 20087676 | 1.71 | 54.6 | Adjuvant (A) | null | 2017-12-09 | CISPLATIN + FLUOROURACIL + RT | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100224496 |
| 20138325 | 20087677 | 1.76 | 0 | Palliative (P) | 2020-07-15 | 2020-07-16 | CISPLATIN + VINORELBINE | 02 | N | SCOPE2 TRIAL | 101400423 |
| 20138373 | 20087678 | 1.6 | 92.8 | Palliative (P) | 2017-01-09 | 2017-01-23 | null | 02 | N | GO2 TRIAL | 101440199 |